1. Home
  2. RZLT vs CMPS Comparison

RZLT vs CMPS Comparison

Compare RZLT & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.26

Market Cap

321.6M

Sector

Health Care

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$11.76

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RZLT
CMPS
Founded
2010
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
321.6M
1.2B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RZLT
CMPS
Price
$3.26
$11.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$9.67
$25.38
AVG Volume (30 Days)
1.3M
4.1M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.32
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$2.25
52 Week High
$11.46
$12.03

Technical Indicators

Market Signals
Indicator
RZLT
CMPS
Relative Strength Index (RSI) 49.88 68.45
Support Level $2.93 $5.95
Resistance Level $3.60 N/A
Average True Range (ATR) 0.21 0.78
MACD -0.00 0.08
Stochastic Oscillator 56.90 83.31

Price Performance

Historical Comparison
RZLT
CMPS

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Share on Social Networks: